thiazolidines has been researched along with Prostatic Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Alam, MA; Alam, O; Haider, MR; Husain, A; Iqbal, MA; Khan, SA | 1 |
| Ben-Salha, I; Costa, H; Echeverria, LMC; Freeman, A; Gately, KA; Haider, A; Heavey, S; Jameson, C; Kelly, JD; Kumar, C; Luszczak, S; Pye, H; Ratynska, M; Sathyadevan, VK; Shaw, G; Simpson, BS; Sridhar, A; Stopka-Farooqui, U; Whitaker, HC | 1 |
| Devi, R; Divakar, S; Elancheran, R; Kabilan, S; Kotoky, J; Kumari, S; Maruthanila, VL; Ramanathan, M; Saravanan, K | 1 |
| Peng, F; Xie, F | 1 |
| Abdulkadir, SA; Ahdesmaki, M; Anderson, PD; Everett, JH; Franco-Coronel, OE; Grosskurth, SE; Hameed, O; Huszar, D; Keeton, EK; Kirschner, AN; Kushner, MH; van der Meer, R; Wang, J | 1 |
| Kraft, AS; Sainz, AG; Song, JH; Warfel, NA | 1 |
| Awad, HM; El-Sayed, WA; El-Sofany, WI; Flefel, EM; Mohamed, AM | 1 |
| Kopeček, J; Yang, J; Zhou, Y | 1 |
| Davis, JJ; Dong, F; Fang, B; Guo, W; Inoue, S; Teraishi, F; Wu, S; Zhang, L | 1 |
| Awate, B; Khanfar, MA; Liu, Y; Muralidharan, A; Nagle, DG; Sayed, KA; Shah, G; Shallal, HM; Youssef, DT; Zhou, YD | 1 |
| Black, J; Ip, MM; Shea, WK | 1 |
| Ip, MM; Schenkel, L; Sylvester, PW | 1 |
12 other study(ies) available for thiazolidines and Prostatic Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Design; Female; Humans; Imidazoles; Lung Neoplasms; Male; MCF-7 Cells; Molecular Docking Simulation; Prostatic Neoplasms; Pyridines; Rats; Rats, Wistar; Thiazolidines; Toxicity Tests | 2020 |
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; Pyrimidines; Quinolines; RNA, Messenger; Signal Transduction; Thiazolidines; Thiophenes; TOR Serine-Threonine Kinases | 2020 |
Design, Synthesis and Biological Evaluation of Novel 1, 3- thiazolidine-2, 4-diones as Anti-prostate Cancer Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Docking Simulation; Prostatic Neoplasms; Thiazolidines | 2017 |
Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Coordination Complexes; Copper; Female; Humans; Male; Microscopy, Fluorescence; Propionates; Prostatic Neoplasms; Thiazolidines; Tumor Cells, Cultured | 2018 |
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
Topics: Administration, Oral; Allografts; Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Hypoxia; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Male; Mice; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Thiazolidines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.
Topics: Animals; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Models, Biological; Neoplasms; NF-E2-Related Factor 2; Prostatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-pim-1; Reactive Oxygen Species; Signal Transduction; Thiazolidines; Xenograft Model Antitumor Assays | 2016 |
Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Colorectal Neoplasms; Glycosylation; HCT116 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Male; Prostatic Neoplasms; Spiro Compounds; Structure-Activity Relationship; Thiadiazoles; Thiazolidines; Thioglycosides | 2017 |
Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Separation; Cell Survival; Hedgehog Proteins; Humans; Male; Methacrylates; Neoplastic Stem Cells; Polymers; Prostatic Neoplasms; Signal Transduction; Thiazolidines; Veratrum Alkaloids | 2012 |
Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 2006 |
Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carbamates; Drug Screening Assays, Antitumor; Humans; Hypoxia-Inducible Factor 1; Male; Molecular Structure; Porifera; Prostatic Neoplasms; Thiazolidines | 2008 |
Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Basement Membrane; Disease Models, Animal; Epithelium; Male; Prostatic Neoplasms; Rats; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 1989 |
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Corticosterone; Female; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Thiazoles; Thiazolidines | 1986 |